KLOW calculator
A branded supplier blend, typically combining the anti-inflammatory peptide KPV with GHK-Cu and repair peptides. Composition varies and is unregulated.
Also known as: KLOW blend, KPV / GHK-Cu repair blend
FDA status — not an approved drug Not FDA-approved. KLOW is a compounded blend of unapproved peptides; the components are not FDA-approved and the blend is not reviewed for safety or quality.
Schedule KLOW → Set your dosing schedule and get a phone notification when each dose is due. Free.
What KLOW is
KLOW is a branded name used by peptide suppliers for a blend, most often combining the anti-inflammatory tripeptide KPV with GHK-Cu and repair peptides. Like GLOW, there is no standardized formula, and the blend has no clinical evidence as a product.
Research depth: 1/5 No evidence for the blend itself; only individual-component preclinical data exists. Human trials: None for the blend. This measures how much has been studied — counting animal and laboratory work — not whether it works for you.
How KLOW works
The blend is marketed on the combined rationale of its components: KPV for anti-inflammatory signaling, GHK-Cu for skin and connective tissue, and repair peptides for healing. With no standard formula and no randomized human data for the components' marketed uses, the blend's effects are uncharacterized.
KLOW side effects
Commonly reported
- Injection-site irritation
- Blue tint if it contains GHK-Cu
- No standardized composition — effects vary by product
Serious — seek medical care
- Unstudied blend with variable composition
- Quality, purity, and dosing vary widely among suppliers
- Anti-inflammatory and angiogenic mechanisms are uncharacterized in combination
This list is not exhaustive. Report anything unexpected to the clinician who prescribed it. If you have severe abdominal pain, trouble breathing, or signs of an allergic reaction, seek care the same day. See also our guide to peptide side effects by class.
A worked example
A 30 mg vial reconstituted with 3 mL of bacteriostatic water gives 10 mg/mL. A 2000 mcg dose is then 0.2 mL — about 20 units on a 100-unit insulin syringe, giving roughly 15 doses per vial before accounting for residual volume left in the vial and syringe.
Prefer paper? Download the printable KLOW dosing chart (PDF) — every vial size and water volume in syringe units, with the same review byline as this page. All charts →
Commonly cited dose range
Figures circulating for KLOW run from 1000 mcg to 5000 mcg. KLOW blends have no standardized composition — amounts vary by supplier. Figures shown are reference points only and do not describe a studied product. Dosing depends entirely on the specific formulation.
Read this as reference information, not instruction. These numbers describe what is commonly discussed, not what is right for any individual. Dose, frequency, and whether to use KLOW at all are decisions for a licensed clinician who knows your history.
Common questions
What's in a KLOW blend?
There is no standard recipe. It typically combines the anti-inflammatory peptide KPV with GHK-Cu and repair peptides, but components and amounts vary by supplier. Check the specific product's label.
Is KLOW approved?
No. It is a compounded blend of unapproved peptides with no standardized formulation and no clinical evidence as a product.